nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Temozolomide—malignant glioma	0.242	1	CbGbCtD
Cevimeline—Abnormal platelets—Temozolomide—malignant glioma	0.0348	0.052	CcSEcCtD
Cevimeline—Platelet disorder—Temozolomide—malignant glioma	0.0277	0.0413	CcSEcCtD
Cevimeline—Paranoid reaction—Carmustine—malignant glioma	0.00977	0.0146	CcSEcCtD
Cevimeline—Personality disorder—Carmustine—malignant glioma	0.0096	0.0143	CcSEcCtD
Cevimeline—Pulmonary fibrosis—Carmustine—malignant glioma	0.00944	0.0141	CcSEcCtD
Cevimeline—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00912	0.0136	CcSEcCtD
Cevimeline—Tongue discolouration—Temozolomide—malignant glioma	0.0083	0.0124	CcSEcCtD
Cevimeline—Haemorrhoids—Temozolomide—malignant glioma	0.00682	0.0102	CcSEcCtD
Cevimeline—Aphasia—Carmustine—malignant glioma	0.0064	0.00955	CcSEcCtD
Cevimeline—Aphasia—Temozolomide—malignant glioma	0.00619	0.00923	CcSEcCtD
Cevimeline—Tooth disorder—Temozolomide—malignant glioma	0.00619	0.00923	CcSEcCtD
Cevimeline—Parosmia—Temozolomide—malignant glioma	0.00619	0.00923	CcSEcCtD
Cevimeline—Paranoia—Carmustine—malignant glioma	0.00609	0.00909	CcSEcCtD
Cevimeline—Apathy—Temozolomide—malignant glioma	0.00562	0.00838	CcSEcCtD
Cevimeline—Influenza-like symptoms—Temozolomide—malignant glioma	0.00562	0.00838	CcSEcCtD
Cevimeline—Flat affect—Temozolomide—malignant glioma	0.00557	0.00831	CcSEcCtD
Cevimeline—Menorrhagia—Temozolomide—malignant glioma	0.00542	0.00809	CcSEcCtD
Cevimeline—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00542	0.00809	CcSEcCtD
Cevimeline—Herpes zoster—Temozolomide—malignant glioma	0.00533	0.00795	CcSEcCtD
Cevimeline—Abscess—Carmustine—malignant glioma	0.00525	0.00783	CcSEcCtD
Cevimeline—Otitis media—Temozolomide—malignant glioma	0.00515	0.00769	CcSEcCtD
Cevimeline—Hyperaesthesia—Temozolomide—malignant glioma	0.00511	0.00763	CcSEcCtD
Cevimeline—Rigors—Temozolomide—malignant glioma	0.00492	0.00733	CcSEcCtD
Cevimeline—Endocrine disorder—Temozolomide—malignant glioma	0.00484	0.00722	CcSEcCtD
Cevimeline—Speech disorder—Carmustine—malignant glioma	0.00483	0.0072	CcSEcCtD
Cevimeline—Speech disorder—Temozolomide—malignant glioma	0.00467	0.00696	CcSEcCtD
Cevimeline—Breast pain—Temozolomide—malignant glioma	0.0046	0.00686	CcSEcCtD
Cevimeline—Amenorrhoea—Temozolomide—malignant glioma	0.00457	0.00682	CcSEcCtD
Cevimeline—Thinking abnormal—Carmustine—malignant glioma	0.00454	0.00677	CcSEcCtD
Cevimeline—Viral infection—Temozolomide—malignant glioma	0.00444	0.00663	CcSEcCtD
Cevimeline—Leukocytosis—Carmustine—malignant glioma	0.00442	0.00659	CcSEcCtD
Cevimeline—Herpes simplex—Temozolomide—malignant glioma	0.00435	0.0065	CcSEcCtD
Cevimeline—Gait disturbance—Carmustine—malignant glioma	0.00425	0.00635	CcSEcCtD
Cevimeline—Coordination abnormal—Carmustine—malignant glioma	0.00423	0.00631	CcSEcCtD
Cevimeline—Hearing impaired—Temozolomide—malignant glioma	0.00422	0.00629	CcSEcCtD
Cevimeline—Pulmonary embolism—Carmustine—malignant glioma	0.00415	0.0062	CcSEcCtD
Cevimeline—Gait disturbance—Temozolomide—malignant glioma	0.00411	0.00614	CcSEcCtD
Cevimeline—Coordination abnormal—Temozolomide—malignant glioma	0.00409	0.0061	CcSEcCtD
Cevimeline—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00401	0.00599	CcSEcCtD
Cevimeline—Vaginal inflammation—Temozolomide—malignant glioma	0.00401	0.00599	CcSEcCtD
Cevimeline—Pulmonary embolism—Temozolomide—malignant glioma	0.00401	0.00599	CcSEcCtD
Cevimeline—Urinary incontinence—Carmustine—malignant glioma	0.00401	0.00598	CcSEcCtD
Cevimeline—Skin exfoliation—Carmustine—malignant glioma	0.00396	0.00592	CcSEcCtD
Cevimeline—Candida infection—Carmustine—malignant glioma	0.00396	0.00592	CcSEcCtD
Cevimeline—Neuropathy—Carmustine—malignant glioma	0.0039	0.00582	CcSEcCtD
Cevimeline—Influenza like illness—Temozolomide—malignant glioma	0.0039	0.00582	CcSEcCtD
Cevimeline—Urinary incontinence—Temozolomide—malignant glioma	0.00387	0.00578	CcSEcCtD
Cevimeline—Skin exfoliation—Temozolomide—malignant glioma	0.00383	0.00572	CcSEcCtD
Cevimeline—Candida infection—Temozolomide—malignant glioma	0.00383	0.00572	CcSEcCtD
Cevimeline—Coma—Carmustine—malignant glioma	0.00379	0.00566	CcSEcCtD
Cevimeline—Vaginal infection—Temozolomide—malignant glioma	0.00379	0.00565	CcSEcCtD
Cevimeline—Neuropathy—Temozolomide—malignant glioma	0.00377	0.00562	CcSEcCtD
Cevimeline—Neoplasm—Carmustine—malignant glioma	0.00375	0.0056	CcSEcCtD
Cevimeline—Neoplasm—Temozolomide—malignant glioma	0.00363	0.00541	CcSEcCtD
Cevimeline—Abnormal vision—Carmustine—malignant glioma	0.00362	0.0054	CcSEcCtD
Cevimeline—Mental disability—Carmustine—malignant glioma	0.0036	0.00538	CcSEcCtD
Cevimeline—Sepsis—Carmustine—malignant glioma	0.0036	0.00538	CcSEcCtD
Cevimeline—Abnormal vision—Temozolomide—malignant glioma	0.0035	0.00522	CcSEcCtD
Cevimeline—Mental disability—Temozolomide—malignant glioma	0.00348	0.0052	CcSEcCtD
Cevimeline—Thrombophlebitis—Carmustine—malignant glioma	0.00348	0.0052	CcSEcCtD
Cevimeline—Diabetes mellitus—Carmustine—malignant glioma	0.00347	0.00517	CcSEcCtD
Cevimeline—Ear pain—Temozolomide—malignant glioma	0.00341	0.00509	CcSEcCtD
Cevimeline—Thrombophlebitis—Temozolomide—malignant glioma	0.00336	0.00502	CcSEcCtD
Cevimeline—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00335	0.005	CcSEcCtD
Cevimeline—Eye pain—Carmustine—malignant glioma	0.00334	0.00498	CcSEcCtD
Cevimeline—Gastroenteritis—Temozolomide—malignant glioma	0.00329	0.0049	CcSEcCtD
Cevimeline—Injury—Carmustine—malignant glioma	0.00328	0.00489	CcSEcCtD
Cevimeline—Vascular purpura—Temozolomide—malignant glioma	0.00326	0.00486	CcSEcCtD
Cevimeline—Deafness—Temozolomide—malignant glioma	0.00326	0.00486	CcSEcCtD
Cevimeline—Eye pain—Temozolomide—malignant glioma	0.00323	0.00482	CcSEcCtD
Cevimeline—Amnesia—Carmustine—malignant glioma	0.00321	0.00479	CcSEcCtD
Cevimeline—Hot flush—Temozolomide—malignant glioma	0.00311	0.00465	CcSEcCtD
Cevimeline—Amnesia—Temozolomide—malignant glioma	0.0031	0.00463	CcSEcCtD
Cevimeline—Menopausal symptoms—Temozolomide—malignant glioma	0.00309	0.00461	CcSEcCtD
Cevimeline—Thirst—Temozolomide—malignant glioma	0.00306	0.00457	CcSEcCtD
Cevimeline—Hyponatraemia—Carmustine—malignant glioma	0.00303	0.00452	CcSEcCtD
Cevimeline—Purpura—Temozolomide—malignant glioma	0.00302	0.00451	CcSEcCtD
Cevimeline—Diplopia—Carmustine—malignant glioma	0.00301	0.0045	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00301	0.0045	CcSEcCtD
Cevimeline—Diplopia—Temozolomide—malignant glioma	0.00291	0.00435	CcSEcCtD
Cevimeline—Face oedema—Carmustine—malignant glioma	0.00291	0.00434	CcSEcCtD
Cevimeline—Affect lability—Temozolomide—malignant glioma	0.00287	0.00428	CcSEcCtD
Cevimeline—Face oedema—Temozolomide—malignant glioma	0.00281	0.0042	CcSEcCtD
Cevimeline—Mood swings—Temozolomide—malignant glioma	0.00276	0.00412	CcSEcCtD
Cevimeline—Hypokalaemia—Carmustine—malignant glioma	0.00274	0.00409	CcSEcCtD
Cevimeline—Dehydration—Temozolomide—malignant glioma	0.00271	0.00404	CcSEcCtD
Cevimeline—Dry skin—Temozolomide—malignant glioma	0.00267	0.00398	CcSEcCtD
Cevimeline—Muscular weakness—Carmustine—malignant glioma	0.00266	0.00397	CcSEcCtD
Cevimeline—Hypokalaemia—Temozolomide—malignant glioma	0.00265	0.00396	CcSEcCtD
Cevimeline—Dysphagia—Carmustine—malignant glioma	0.00261	0.00389	CcSEcCtD
Cevimeline—Muscular weakness—Temozolomide—malignant glioma	0.00257	0.00383	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00257	0.00383	CcSEcCtD
Cevimeline—Abdominal distension—Temozolomide—malignant glioma	0.00253	0.00378	CcSEcCtD
Cevimeline—Dysphagia—Temozolomide—malignant glioma	0.00252	0.00376	CcSEcCtD
Cevimeline—Sweating increased—Temozolomide—malignant glioma	0.00245	0.00366	CcSEcCtD
Cevimeline—Bronchitis—Temozolomide—malignant glioma	0.00242	0.00361	CcSEcCtD
Cevimeline—Dysuria—Temozolomide—malignant glioma	0.00235	0.00351	CcSEcCtD
Cevimeline—Hyperglycaemia—Carmustine—malignant glioma	0.00235	0.00351	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00234	0.00349	CcSEcCtD
Cevimeline—Pneumonia—Carmustine—malignant glioma	0.00234	0.00349	CcSEcCtD
Cevimeline—Pollakiuria—Temozolomide—malignant glioma	0.00233	0.00347	CcSEcCtD
Cevimeline—Erectile dysfunction—Temozolomide—malignant glioma	0.00232	0.00346	CcSEcCtD
Cevimeline—Depression—Carmustine—malignant glioma	0.00232	0.00346	CcSEcCtD
Cevimeline—Photosensitivity reaction—Temozolomide—malignant glioma	0.0023	0.00343	CcSEcCtD
Cevimeline—Weight increased—Temozolomide—malignant glioma	0.00229	0.00342	CcSEcCtD
Cevimeline—Weight decreased—Temozolomide—malignant glioma	0.00228	0.0034	CcSEcCtD
Cevimeline—Neuropathy peripheral—Carmustine—malignant glioma	0.00228	0.0034	CcSEcCtD
Cevimeline—Hyperglycaemia—Temozolomide—malignant glioma	0.00227	0.00339	CcSEcCtD
Cevimeline—Stomatitis—Carmustine—malignant glioma	0.00226	0.00338	CcSEcCtD
Cevimeline—Urinary tract infection—Carmustine—malignant glioma	0.00226	0.00337	CcSEcCtD
Cevimeline—Pneumonia—Temozolomide—malignant glioma	0.00226	0.00337	CcSEcCtD
Cevimeline—Depression—Temozolomide—malignant glioma	0.00224	0.00334	CcSEcCtD
Cevimeline—Neuropathy peripheral—Temozolomide—malignant glioma	0.0022	0.00328	CcSEcCtD
Cevimeline—Stomatitis—Temozolomide—malignant glioma	0.00219	0.00327	CcSEcCtD
Cevimeline—Urinary tract infection—Temozolomide—malignant glioma	0.00218	0.00326	CcSEcCtD
Cevimeline—Sinusitis—Temozolomide—malignant glioma	0.00211	0.00314	CcSEcCtD
Cevimeline—Haemoglobin—Carmustine—malignant glioma	0.0021	0.00313	CcSEcCtD
Cevimeline—Haemorrhage—Carmustine—malignant glioma	0.00209	0.00311	CcSEcCtD
Cevimeline—Hallucination—Carmustine—malignant glioma	0.00207	0.0031	CcSEcCtD
Cevimeline—Hypoaesthesia—Carmustine—malignant glioma	0.00207	0.0031	CcSEcCtD
Cevimeline—Oedema peripheral—Carmustine—malignant glioma	0.00205	0.00307	CcSEcCtD
Cevimeline—Haemoglobin—Temozolomide—malignant glioma	0.00203	0.00302	CcSEcCtD
Cevimeline—Haemorrhage—Temozolomide—malignant glioma	0.00202	0.00301	CcSEcCtD
Cevimeline—Visual impairment—Carmustine—malignant glioma	0.00201	0.003	CcSEcCtD
Cevimeline—Hypoaesthesia—Temozolomide—malignant glioma	0.00201	0.00299	CcSEcCtD
Cevimeline—Hallucination—Temozolomide—malignant glioma	0.00201	0.00299	CcSEcCtD
Cevimeline—Pharyngitis—Temozolomide—malignant glioma	0.002	0.00298	CcSEcCtD
Cevimeline—Oedema peripheral—Temozolomide—malignant glioma	0.00199	0.00296	CcSEcCtD
Cevimeline—Urethral disorder—Temozolomide—malignant glioma	0.00198	0.00295	CcSEcCtD
Cevimeline—Eye disorder—Carmustine—malignant glioma	0.00195	0.00291	CcSEcCtD
Cevimeline—Visual impairment—Temozolomide—malignant glioma	0.00194	0.0029	CcSEcCtD
Cevimeline—Flushing—Carmustine—malignant glioma	0.00194	0.00289	CcSEcCtD
Cevimeline—Eye disorder—Temozolomide—malignant glioma	0.00188	0.00281	CcSEcCtD
Cevimeline—Tinnitus—Temozolomide—malignant glioma	0.00188	0.0028	CcSEcCtD
Cevimeline—Cardiac disorder—Temozolomide—malignant glioma	0.00187	0.00279	CcSEcCtD
Cevimeline—Flushing—Temozolomide—malignant glioma	0.00187	0.00279	CcSEcCtD
Cevimeline—Arrhythmia—Carmustine—malignant glioma	0.00186	0.00278	CcSEcCtD
Cevimeline—Alopecia—Carmustine—malignant glioma	0.00184	0.00275	CcSEcCtD
Cevimeline—Angiopathy—Temozolomide—malignant glioma	0.00183	0.00273	CcSEcCtD
Cevimeline—Malnutrition—Carmustine—malignant glioma	0.00182	0.00271	CcSEcCtD
Cevimeline—Chills—Temozolomide—malignant glioma	0.00181	0.0027	CcSEcCtD
Cevimeline—Alopecia—Temozolomide—malignant glioma	0.00178	0.00266	CcSEcCtD
Cevimeline—Back pain—Carmustine—malignant glioma	0.00176	0.00262	CcSEcCtD
Cevimeline—Malnutrition—Temozolomide—malignant glioma	0.00175	0.00262	CcSEcCtD
Cevimeline—Dysgeusia—Temozolomide—malignant glioma	0.00172	0.00256	CcSEcCtD
Cevimeline—Tremor—Carmustine—malignant glioma	0.0017	0.00254	CcSEcCtD
Cevimeline—Back pain—Temozolomide—malignant glioma	0.0017	0.00253	CcSEcCtD
Cevimeline—Anaemia—Carmustine—malignant glioma	0.00168	0.0025	CcSEcCtD
Cevimeline—Agitation—Carmustine—malignant glioma	0.00167	0.00249	CcSEcCtD
Cevimeline—Tremor—Temozolomide—malignant glioma	0.00164	0.00245	CcSEcCtD
Cevimeline—Ill-defined disorder—Temozolomide—malignant glioma	0.00163	0.00243	CcSEcCtD
Cevimeline—Leukopenia—Carmustine—malignant glioma	0.00162	0.00242	CcSEcCtD
Cevimeline—Anaemia—Temozolomide—malignant glioma	0.00162	0.00242	CcSEcCtD
Cevimeline—Agitation—Temozolomide—malignant glioma	0.00161	0.00241	CcSEcCtD
Cevimeline—Malaise—Temozolomide—malignant glioma	0.00158	0.00236	CcSEcCtD
Cevimeline—Vertigo—Temozolomide—malignant glioma	0.00158	0.00235	CcSEcCtD
Cevimeline—Convulsion—Carmustine—malignant glioma	0.00157	0.00235	CcSEcCtD
Cevimeline—Leukopenia—Temozolomide—malignant glioma	0.00157	0.00234	CcSEcCtD
Cevimeline—Hypertension—Carmustine—malignant glioma	0.00157	0.00234	CcSEcCtD
Cevimeline—Palpitations—Temozolomide—malignant glioma	0.00155	0.00231	CcSEcCtD
Cevimeline—Myalgia—Carmustine—malignant glioma	0.00155	0.00231	CcSEcCtD
Cevimeline—Chest pain—Carmustine—malignant glioma	0.00155	0.00231	CcSEcCtD
Cevimeline—Anxiety—Carmustine—malignant glioma	0.00154	0.0023	CcSEcCtD
Cevimeline—Cough—Temozolomide—malignant glioma	0.00153	0.00228	CcSEcCtD
Cevimeline—Convulsion—Temozolomide—malignant glioma	0.00152	0.00227	CcSEcCtD
Cevimeline—Hypertension—Temozolomide—malignant glioma	0.00151	0.00226	CcSEcCtD
Cevimeline—Confusional state—Carmustine—malignant glioma	0.00149	0.00223	CcSEcCtD
Cevimeline—Myalgia—Temozolomide—malignant glioma	0.00149	0.00223	CcSEcCtD
Cevimeline—Arthralgia—Temozolomide—malignant glioma	0.00149	0.00223	CcSEcCtD
Cevimeline—Anxiety—Temozolomide—malignant glioma	0.00149	0.00222	CcSEcCtD
Cevimeline—Oedema—Carmustine—malignant glioma	0.00148	0.00221	CcSEcCtD
Cevimeline—Discomfort—Temozolomide—malignant glioma	0.00148	0.0022	CcSEcCtD
Cevimeline—Infection—Carmustine—malignant glioma	0.00147	0.0022	CcSEcCtD
Cevimeline—Thrombocytopenia—Carmustine—malignant glioma	0.00145	0.00216	CcSEcCtD
Cevimeline—Tachycardia—Carmustine—malignant glioma	0.00145	0.00216	CcSEcCtD
Cevimeline—Confusional state—Temozolomide—malignant glioma	0.00144	0.00215	CcSEcCtD
Cevimeline—Oedema—Temozolomide—malignant glioma	0.00143	0.00214	CcSEcCtD
Cevimeline—Infection—Temozolomide—malignant glioma	0.00142	0.00212	CcSEcCtD
Cevimeline—Anorexia—Carmustine—malignant glioma	0.00141	0.00211	CcSEcCtD
Cevimeline—Nervous system disorder—Temozolomide—malignant glioma	0.0014	0.0021	CcSEcCtD
Cevimeline—Thrombocytopenia—Temozolomide—malignant glioma	0.0014	0.00209	CcSEcCtD
Cevimeline—Skin disorder—Temozolomide—malignant glioma	0.00139	0.00208	CcSEcCtD
Cevimeline—Hypotension—Carmustine—malignant glioma	0.00138	0.00207	CcSEcCtD
Cevimeline—Hyperhidrosis—Temozolomide—malignant glioma	0.00138	0.00207	CcSEcCtD
Cevimeline—Anorexia—Temozolomide—malignant glioma	0.00136	0.00204	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00135	0.00201	CcSEcCtD
Cevimeline—Insomnia—Carmustine—malignant glioma	0.00134	0.002	CcSEcCtD
Cevimeline—Paraesthesia—Carmustine—malignant glioma	0.00133	0.00199	CcSEcCtD
Cevimeline—Dyspnoea—Carmustine—malignant glioma	0.00132	0.00197	CcSEcCtD
Cevimeline—Somnolence—Carmustine—malignant glioma	0.00132	0.00197	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0013	0.00195	CcSEcCtD
Cevimeline—Insomnia—Temozolomide—malignant glioma	0.00129	0.00193	CcSEcCtD
Cevimeline—Decreased appetite—Carmustine—malignant glioma	0.00129	0.00192	CcSEcCtD
Cevimeline—Paraesthesia—Temozolomide—malignant glioma	0.00129	0.00192	CcSEcCtD
Cevimeline—Dyspnoea—Temozolomide—malignant glioma	0.00128	0.0019	CcSEcCtD
Cevimeline—Somnolence—Temozolomide—malignant glioma	0.00127	0.0019	CcSEcCtD
Cevimeline—Constipation—Carmustine—malignant glioma	0.00127	0.00189	CcSEcCtD
Cevimeline—Pain—Carmustine—malignant glioma	0.00127	0.00189	CcSEcCtD
Cevimeline—Dyspepsia—Temozolomide—malignant glioma	0.00126	0.00188	CcSEcCtD
Cevimeline—Decreased appetite—Temozolomide—malignant glioma	0.00124	0.00186	CcSEcCtD
Cevimeline—Fatigue—Temozolomide—malignant glioma	0.00123	0.00184	CcSEcCtD
Cevimeline—Pain—Temozolomide—malignant glioma	0.00122	0.00183	CcSEcCtD
Cevimeline—Constipation—Temozolomide—malignant glioma	0.00122	0.00183	CcSEcCtD
Cevimeline—Feeling abnormal—Carmustine—malignant glioma	0.00122	0.00182	CcSEcCtD
Cevimeline—Gastrointestinal pain—Carmustine—malignant glioma	0.00121	0.00181	CcSEcCtD
Cevimeline—Feeling abnormal—Temozolomide—malignant glioma	0.00118	0.00176	CcSEcCtD
Cevimeline—Body temperature increased—Carmustine—malignant glioma	0.00117	0.00175	CcSEcCtD
Cevimeline—Abdominal pain—Carmustine—malignant glioma	0.00117	0.00175	CcSEcCtD
Cevimeline—Gastrointestinal pain—Temozolomide—malignant glioma	0.00117	0.00175	CcSEcCtD
Cevimeline—Urticaria—Temozolomide—malignant glioma	0.00114	0.0017	CcSEcCtD
Cevimeline—Abdominal pain—Temozolomide—malignant glioma	0.00113	0.00169	CcSEcCtD
Cevimeline—Body temperature increased—Temozolomide—malignant glioma	0.00113	0.00169	CcSEcCtD
Cevimeline—Hypersensitivity—Carmustine—malignant glioma	0.00109	0.00163	CcSEcCtD
Cevimeline—Asthenia—Carmustine—malignant glioma	0.00106	0.00159	CcSEcCtD
Cevimeline—Hypersensitivity—Temozolomide—malignant glioma	0.00105	0.00157	CcSEcCtD
Cevimeline—Asthenia—Temozolomide—malignant glioma	0.00103	0.00153	CcSEcCtD
Cevimeline—Diarrhoea—Carmustine—malignant glioma	0.00101	0.00151	CcSEcCtD
Cevimeline—Pruritus—Temozolomide—malignant glioma	0.00101	0.00151	CcSEcCtD
Cevimeline—Dizziness—Carmustine—malignant glioma	0.00098	0.00146	CcSEcCtD
Cevimeline—Diarrhoea—Temozolomide—malignant glioma	0.00098	0.00146	CcSEcCtD
Cevimeline—Dizziness—Temozolomide—malignant glioma	0.000947	0.00141	CcSEcCtD
Cevimeline—Vomiting—Carmustine—malignant glioma	0.000942	0.00141	CcSEcCtD
Cevimeline—Rash—Carmustine—malignant glioma	0.000934	0.00139	CcSEcCtD
Cevimeline—Dermatitis—Carmustine—malignant glioma	0.000933	0.00139	CcSEcCtD
Cevimeline—Headache—Carmustine—malignant glioma	0.000928	0.00139	CcSEcCtD
Cevimeline—Vomiting—Temozolomide—malignant glioma	0.00091	0.00136	CcSEcCtD
Cevimeline—Rash—Temozolomide—malignant glioma	0.000903	0.00135	CcSEcCtD
Cevimeline—Dermatitis—Temozolomide—malignant glioma	0.000902	0.00135	CcSEcCtD
Cevimeline—Headache—Temozolomide—malignant glioma	0.000897	0.00134	CcSEcCtD
Cevimeline—Nausea—Carmustine—malignant glioma	0.00088	0.00131	CcSEcCtD
Cevimeline—Nausea—Temozolomide—malignant glioma	0.00085	0.00127	CcSEcCtD
Cevimeline—CHRM1—Signaling by GPCR—BDKRB2—malignant glioma	6.93e-05	0.000791	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—KNG1—malignant glioma	6.92e-05	0.000789	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—BDKRB2—malignant glioma	6.91e-05	0.000788	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	6.86e-05	0.000782	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	6.83e-05	0.000779	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SUFU—malignant glioma	6.59e-05	0.000751	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SUFU—malignant glioma	6.57e-05	0.000749	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BCAN—malignant glioma	6.54e-05	0.000745	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HEY2—malignant glioma	6.51e-05	0.000742	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HEY2—malignant glioma	6.49e-05	0.00074	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—TP53—malignant glioma	6.43e-05	0.000733	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GFAP—malignant glioma	6.36e-05	0.000725	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GFAP—malignant glioma	6.34e-05	0.000722	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—KNG1—malignant glioma	6.31e-05	0.000719	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	6.3e-05	0.000718	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—KNG1—malignant glioma	6.29e-05	0.000717	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	6.28e-05	0.000716	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SPHK1—malignant glioma	6.15e-05	0.000701	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SPHK1—malignant glioma	6.13e-05	0.000699	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HEY1—malignant glioma	6.03e-05	0.000687	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR4—malignant glioma	6.03e-05	0.000687	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR4—malignant glioma	6.01e-05	0.000685	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HEY1—malignant glioma	6.01e-05	0.000685	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HIST1H3B—malignant glioma	5.85e-05	0.000667	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HIST1H3B—malignant glioma	5.84e-05	0.000665	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—malignant glioma	5.81e-05	0.000662	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL8—malignant glioma	5.6e-05	0.000638	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MMP3—malignant glioma	5.59e-05	0.000637	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL8—malignant glioma	5.58e-05	0.000636	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MMP3—malignant glioma	5.57e-05	0.000635	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS1—malignant glioma	5.44e-05	0.000621	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—COX8A—malignant glioma	5.35e-05	0.000609	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JAG2—malignant glioma	5.34e-05	0.000609	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JAG2—malignant glioma	5.33e-05	0.000607	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—IDH2—malignant glioma	5.27e-05	0.000601	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PIK3CA—malignant glioma	5.16e-05	0.000588	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—BCHE—malignant glioma	5.06e-05	0.000577	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC5A5—malignant glioma	5e-05	0.00057	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.95e-05	0.000565	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ASMT—malignant glioma	4.55e-05	0.000518	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—IDH1—malignant glioma	4.53e-05	0.000517	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—H3F3A—malignant glioma	4.52e-05	0.000516	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—H3F3A—malignant glioma	4.51e-05	0.000514	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—F2—malignant glioma	4.49e-05	0.000512	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCR3—malignant glioma	4.48e-05	0.000511	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—F2—malignant glioma	4.48e-05	0.00051	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCR3—malignant glioma	4.46e-05	0.000509	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SPHK1—malignant glioma	4.38e-05	0.0005	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK2—malignant glioma	4.36e-05	0.000497	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—YWHAE—malignant glioma	4.36e-05	0.000497	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK2—malignant glioma	4.34e-05	0.000495	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—YWHAE—malignant glioma	4.34e-05	0.000495	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FLT1—malignant glioma	4.34e-05	0.000494	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FLT1—malignant glioma	4.32e-05	0.000493	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DUSP6—malignant glioma	4.32e-05	0.000492	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DUSP6—malignant glioma	4.3e-05	0.000491	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CG—malignant glioma	4.3e-05	0.00049	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.3e-05	0.00049	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CG—malignant glioma	4.28e-05	0.000488	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BCAN—malignant glioma	4.27e-05	0.000487	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—JAG1—malignant glioma	4.26e-05	0.000486	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—JAG1—malignant glioma	4.25e-05	0.000485	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH3—malignant glioma	4.25e-05	0.000484	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH3—malignant glioma	4.23e-05	0.000482	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—malignant glioma	4.22e-05	0.000481	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FBXW7—malignant glioma	4.18e-05	0.000476	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FBXW7—malignant glioma	4.16e-05	0.000475	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BDKRB2—malignant glioma	4.1e-05	0.000467	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BDKRB2—malignant glioma	4.08e-05	0.000465	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—F2—malignant glioma	4.08e-05	0.000465	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—F2—malignant glioma	4.06e-05	0.000463	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTP1—malignant glioma	4.03e-05	0.000459	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT2—malignant glioma	3.93e-05	0.000448	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT2—malignant glioma	3.92e-05	0.000447	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAT—malignant glioma	3.92e-05	0.000447	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CG—malignant glioma	3.9e-05	0.000445	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CG—malignant glioma	3.89e-05	0.000443	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PTPN11—malignant glioma	3.83e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PTPN11—malignant glioma	3.82e-05	0.000436	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH2—malignant glioma	3.81e-05	0.000434	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH2—malignant glioma	3.8e-05	0.000433	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CD—malignant glioma	3.78e-05	0.000431	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CD—malignant glioma	3.77e-05	0.000429	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KNG1—malignant glioma	3.73e-05	0.000425	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KNG1—malignant glioma	3.71e-05	0.000424	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NCOR1—malignant glioma	3.7e-05	0.000422	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT2—malignant glioma	3.57e-05	0.000407	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT2—malignant glioma	3.56e-05	0.000406	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK1—malignant glioma	3.55e-05	0.000405	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK1—malignant glioma	3.54e-05	0.000404	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—malignant glioma	3.47e-05	0.000396	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IDH2—malignant glioma	3.44e-05	0.000393	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	3.43e-05	0.000391	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	3.42e-05	0.00039	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP3—malignant glioma	3.3e-05	0.000376	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	3.29e-05	0.000375	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP3—malignant glioma	3.29e-05	0.000375	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	3.28e-05	0.000374	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	3.27e-05	0.000373	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	3.26e-05	0.000372	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS1—malignant glioma	3.26e-05	0.000371	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.24e-05	0.000369	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTK2—malignant glioma	3.18e-05	0.000362	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTK2—malignant glioma	3.17e-05	0.000361	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	3.16e-05	0.000361	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	3.15e-05	0.00036	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HES1—malignant glioma	3.12e-05	0.000356	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HES1—malignant glioma	3.11e-05	0.000355	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NCOR1—malignant glioma	3.1e-05	0.000354	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NCOR1—malignant glioma	3.09e-05	0.000353	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RAF1—malignant glioma	3.06e-05	0.000349	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RAF1—malignant glioma	3.05e-05	0.000348	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BCHE—malignant glioma	3.03e-05	0.000345	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2—malignant glioma	3.02e-05	0.000345	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—malignant glioma	3.02e-05	0.000344	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2—malignant glioma	3.01e-05	0.000344	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	2.99e-05	0.000341	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.99e-05	0.000341	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	2.98e-05	0.00034	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	2.97e-05	0.000339	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	2.96e-05	0.000338	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IDH1—malignant glioma	2.96e-05	0.000338	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SPP1—malignant glioma	2.89e-05	0.000329	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SPP1—malignant glioma	2.88e-05	0.000328	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	2.87e-05	0.000328	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SPHK1—malignant glioma	2.87e-05	0.000327	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	2.86e-05	0.000327	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.81e-05	0.00032	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CG—malignant glioma	2.75e-05	0.000313	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2—malignant glioma	2.75e-05	0.000313	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2—malignant glioma	2.74e-05	0.000312	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TERT—malignant glioma	2.74e-05	0.000312	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TERT—malignant glioma	2.73e-05	0.000311	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFB—malignant glioma	2.67e-05	0.000304	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFB—malignant glioma	2.66e-05	0.000303	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGFR1—malignant glioma	2.66e-05	0.000303	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—malignant glioma	2.65e-05	0.000302	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGFR1—malignant glioma	2.65e-05	0.000302	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HIF1A—malignant glioma	2.62e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HIF1A—malignant glioma	2.61e-05	0.000297	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—malignant glioma	2.53e-05	0.000289	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—malignant glioma	2.52e-05	0.000288	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KDR—malignant glioma	2.5e-05	0.000285	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KDR—malignant glioma	2.49e-05	0.000284	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CD—malignant glioma	2.42e-05	0.000275	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2—malignant glioma	2.41e-05	0.000275	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FN1—malignant glioma	2.41e-05	0.000275	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTP1—malignant glioma	2.41e-05	0.000275	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2—malignant glioma	2.4e-05	0.000274	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FN1—malignant glioma	2.4e-05	0.000274	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BAD—malignant glioma	2.38e-05	0.000271	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BAD—malignant glioma	2.37e-05	0.00027	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	2.36e-05	0.000269	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	2.35e-05	0.000268	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAT—malignant glioma	2.34e-05	0.000267	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD80—malignant glioma	2.31e-05	0.000263	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	2.3e-05	0.000263	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APC—malignant glioma	2.3e-05	0.000263	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD80—malignant glioma	2.3e-05	0.000262	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APC—malignant glioma	2.3e-05	0.000262	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	2.3e-05	0.000262	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGF—malignant glioma	2.28e-05	0.00026	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—malignant glioma	2.27e-05	0.000259	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGF—malignant glioma	2.27e-05	0.000259	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTPN11—malignant glioma	2.26e-05	0.000258	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTPN11—malignant glioma	2.26e-05	0.000257	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NCOR1—malignant glioma	2.21e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BRAF—malignant glioma	2.17e-05	0.000247	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BRAF—malignant glioma	2.16e-05	0.000246	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS1—malignant glioma	2.13e-05	0.000243	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT2—malignant glioma	2.11e-05	0.00024	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CB—malignant glioma	2.11e-05	0.00024	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT2—malignant glioma	2.1e-05	0.00024	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—malignant glioma	2.1e-05	0.000239	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—malignant glioma	2.09e-05	0.000239	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—malignant glioma	2.09e-05	0.000238	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	2.03e-05	0.000231	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	2.02e-05	0.00023	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	2.01e-05	0.000229	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	2e-05	0.000228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—KRAS—malignant glioma	1.98e-05	0.000226	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BCHE—malignant glioma	1.98e-05	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—KRAS—malignant glioma	1.98e-05	0.000225	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.95e-05	0.000223	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF2—malignant glioma	1.94e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF2—malignant glioma	1.93e-05	0.00022	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	1.82e-05	0.000208	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTEN—malignant glioma	1.82e-05	0.000207	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	1.82e-05	0.000207	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MDM2—malignant glioma	1.82e-05	0.000207	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MDM2—malignant glioma	1.81e-05	0.000206	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RAF1—malignant glioma	1.81e-05	0.000206	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—malignant glioma	1.8e-05	0.000206	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RAF1—malignant glioma	1.8e-05	0.000206	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB2—malignant glioma	1.79e-05	0.000204	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB2—malignant glioma	1.78e-05	0.000203	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	1.77e-05	0.000201	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	1.76e-05	0.000201	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—malignant glioma	1.7e-05	0.000194	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—malignant glioma	1.69e-05	0.000193	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.64e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	1.64e-05	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	1.63e-05	0.000186	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—malignant glioma	1.62e-05	0.000185	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2—malignant glioma	1.62e-05	0.000185	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—malignant glioma	1.62e-05	0.000185	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2—malignant glioma	1.62e-05	0.000184	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—malignant glioma	1.59e-05	0.000181	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTP1—malignant glioma	1.57e-05	0.000179	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—malignant glioma	1.54e-05	0.000175	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAT—malignant glioma	1.53e-05	0.000175	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—malignant glioma	1.53e-05	0.000174	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTEN—malignant glioma	1.53e-05	0.000174	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTEN—malignant glioma	1.52e-05	0.000173	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—malignant glioma	1.49e-05	0.00017	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—malignant glioma	1.48e-05	0.000169	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NCOR1—malignant glioma	1.45e-05	0.000165	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.44e-05	0.000165	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—malignant glioma	1.38e-05	0.000157	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—malignant glioma	1.37e-05	0.000157	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—malignant glioma	1.36e-05	0.000156	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—malignant glioma	1.36e-05	0.000155	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CA—malignant glioma	1.28e-05	0.000146	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MYC—malignant glioma	1.27e-05	0.000145	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MYC—malignant glioma	1.26e-05	0.000144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.26e-05	0.000144	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—malignant glioma	1.25e-05	0.000142	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—malignant glioma	1.24e-05	0.000141	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—malignant glioma	1.24e-05	0.000141	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—malignant glioma	1.18e-05	0.000134	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KRAS—malignant glioma	1.17e-05	0.000134	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KRAS—malignant glioma	1.17e-05	0.000133	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTEN—malignant glioma	1.09e-05	0.000124	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.08e-05	0.000123	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.07e-05	0.000122	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.07e-05	0.000122	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—malignant glioma	1.05e-05	0.00012	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—malignant glioma	1.04e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—malignant glioma	1.04e-05	0.000118	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—malignant glioma	1.04e-05	0.000118	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.44e-06	0.000108	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—malignant glioma	8.8e-06	0.0001	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—malignant glioma	8.77e-06	0.0001	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.23e-06	9.38e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—malignant glioma	8.16e-06	9.3e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.67e-06	8.75e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTEN—malignant glioma	7.11e-06	8.11e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—malignant glioma	6.27e-06	7.15e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.02e-06	5.72e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—malignant glioma	4.1e-06	4.67e-05	CbGpPWpGaD
